Pharma channel feed – Endpoints News

Pharma channel feed

Boehringer Ingelheim deepens its collaboration with Click Therapeutics in a deal worth $460M

3 years ago

Novartis to cut 280+ jobs in New Jersey

3 years ago

EC approves first allogeneic T cell therapy for rare post-transplant complication

3 years ago

FDA reports shortages for two of Eli Lilly's diabetes drugs will extend into next year

3 years ago

AbbVie adds depression indication to Vraylar's label months after Gonzalez touts $4B+ peak sales potential

3 years ago

Genentech and Biogen pen royalty deal for blood cancer drug with big potential

3 years ago

Q&A: Ireland biopharma leader discusses the nation’s 2022 boost in manufacturing

3 years ago

Blackstone reconsiders future of Japanese pharma — report

3 years ago

US-listed Chinese biotechs dodge threat of delisting

3 years ago

AstraZeneca nabs 6 more months for Symbicort patent in latest court ruling

3 years ago

Despite 'lackluster' 2022, PwC remains 'bullish' on pharma M&A in 2023

3 years ago

AbbVie opts out of industry trade groups PhRMA, BIO plus Business Roundtable

3 years ago

Updated: FDA punts PDUFA date for another indication for AstraZeneca, Merck's cancer drug Lynparza

3 years ago

Merck marks 1M Minecraft downloads in gaming-meets-science education effort

3 years ago

US set to pay nearly $2B for Pfizer's Covid-19 treatment Paxlovid in 2023

3 years ago

Catalent to build a $40M analytical services facility in North Carolina's Research Triangle

3 years ago

Aligning drug prices with ICER estimates could save tens of billions of dollars — JAMA paper

3 years ago

Vanda loses Hetlioz patent court decision, vows to appeal and ask for stay on Teva, Apotex competitors

3 years ago

Novartis offloads five eye drugs in deal worth up to $175M

3 years ago

And then there were 8: Fresenius nabs the latest Humira biosimilar approval

3 years ago

After #ASH22: Post-mortem analysis on biggest Twitter buzz around drugs, studies and biopharmas

3 years ago

Eli Lilly anticipates revenue boost in 2023 as it prepares to launch slate of new drugs

3 years ago

Indonesia's state-owned pharma company strikes deal to manufacture Merck’s HPV vaccine

3 years ago

Novo Nordisk addresses off-label Ozempic use as it grapples with multiple shortages

3 years ago

First page Previous page 155 156 157158159 160 161 Next page Last page